Literature DB >> 2308763

The Pain Disability Index: psychometric properties.

Raymond C Tait1, John T Chibnall, Steven Krause.   

Abstract

This paper reports two studies of chronic pain patients (n = 444) relevant to the psychometric properties of the Pain Disability Index (PDI), a self-report instrument that has been used to assess the degree to which chronic pain interferes with various daily activities. In the first study, patients with high PDI scores reported more psychological distress (P less than 0.001), more severe pain characteristics (P less than 0.001), and more restriction of activities (P less than 0.001) than patients with low PDI scores, findings supportive of the construct validity of the measure. Further, a multiple regression showed that a linear combination of 9 variables predicted PDI scores (R = 0.74): time spent in bed, psychosomatic symptoms, stopping activities because of pain, work status, pain duration, usual pain intensity, quality of life, pain extent, and education. This study also showed differences for age and gender on disability. The second study involved 46 patients who had undergone inpatient treatment for their pain conditions. The study revealed modest test-retest reliability for the instrument. It also showed the PDI to be associated with the levels of pain behavior exhibited by these patients. The findings of both studies generally support the reliability and validity of the PDI as a brief measure of pain-related disability. Questions regarding its test-retest reliability and lack of association with certain pain behaviors are discussed, as are suggestions for future research.

Entities:  

Mesh:

Year:  1990        PMID: 2308763     DOI: 10.1016/0304-3959(90)90068-O

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  202 in total

1.  Assessment and measurement of pain in older adults.

Authors:  K A Herr; L Garand
Journal:  Clin Geriatr Med       Date:  2001-08       Impact factor: 3.076

2.  Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome.

Authors:  T Siessmeier; W A Nix; J Hardt; M Schreckenberger; U T Egle; P Bartenstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

3.  Coping, catastrophizing and chronic pain in breast cancer.

Authors:  Scott R Bishop; David Warr
Journal:  J Behav Med       Date:  2003-06

4.  What is the rate of functional improvement during occupational rehabilitation in workers' compensation claimants?

Authors:  Douglas P Gross; Calvin Haws; Riikka Niemeläinen
Journal:  J Occup Rehabil       Date:  2012-09

Review 5.  Phenotyping and genotyping neuropathic pain.

Authors:  Inna Belfer; Feng Dai
Journal:  Curr Pain Headache Rep       Date:  2010-06

6.  Activity Restriction and Depressive Symptoms in Older Couples.

Authors:  Jeong Eun Lee; Lynn M Martire; Steve H Zarit; Michael J Rovine
Journal:  J Aging Health       Date:  2016-07-19

7.  Secondary prevention of work disability: community-based psychosocial intervention for musculoskeletal disorders.

Authors:  Michael J L Sullivan; L Charles Ward; Dean Tripp; Douglas J French; Heather Adams; William D Stanish
Journal:  J Occup Rehabil       Date:  2005-09

8.  [Organized pain management in the DRG reimbursement system].

Authors:  G Lindena; H U Gerbershagen; M Zenz; H Laubenthal; A Schleppers
Journal:  Schmerz       Date:  2005-02       Impact factor: 1.107

9.  Smoking behavior and motivation to quit among chronic pain patients initiating multidisciplinary pain treatment: a prospective study.

Authors:  Marina Unrod; Ronald J Gironda; Michael E Clark; Kristi E White; Vani N Simmons; Steven K Sutton; Thomas H Brandon
Journal:  Pain Med       Date:  2014-02-15       Impact factor: 3.750

10.  Reliability of the clinical examination in the diagnosis of neurogenic versus vascular claudication.

Authors:  Andrew J Haig; Paul Park; Peter K Henke; Karen S J Yamakawa; Christy Tomkins-Lane; Juan Valdivia; Sierra Loar
Journal:  Spine J       Date:  2013-09-14       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.